Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ) has issued an announcement.
Hansoh Pharmaceutical Group Company Limited has announced a board meeting scheduled for August 18, 2025, to consider and approve the interim results for the first half of the year and discuss the recommendation of an interim dividend. This meeting is significant as it may impact the company’s financial strategies and stakeholder interests.
The most recent analyst rating on (HK:3692) stock is a Buy with a HK$34.83 price target. To see the full list of analyst forecasts on Hansoh Pharmaceutical Group Company Limited stock, see the HK:3692 Stock Forecast page.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, production, and sale of pharmaceutical products.
Average Trading Volume: 11,695,934
Technical Sentiment Signal: Buy
Current Market Cap: HK$207.6B
Learn more about 3692 stock on TipRanks’ Stock Analysis page.